Top former Alnylam exec Barry Greene named CEO of Sage Therapeutics
December 16, 2020 at 09:14 AM EST
Jeff Jonas is stepping down as CEO of Sage Therapeutics and will be replaced by longtime Alnylam Pharmaceuticals executive Barry Greene.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|